|Printable version||E-mail this to a friend|
BHF - Blood pressure treatment breakthrough
High blood pressure can be caused by a tiny organ that senses oxygen levels in the blood, according to new research we funded with your donations.
Researchers at the University of Bristol discovered that this organ, which is no bigger than a grain of rice, can be targeted to treat high blood pressure. The organ is a pair of 'carotid bodies' in the neck on either side of the throat between two major arteries that feed blood to the brain.
As part of the study, published in the American College of Cardiology journal Basic to Translational Science, patients had one of these carotid bodies and experienced an immediate and sustained drop in blood pressure. This procedure was carried out on a small group of 15 people with high blood pressure as part of a pilot trial to see if the treatment was safe.
A potential game changer
Lead researcher Professor Julian Paton, whose research BHF have funded for many years, said: "Treating the carotid body is a novel approach and a potential game changer, as we believe we are reducing one of the main causes for hypertension in many patients.
"High blood pressure treatment typically tackles the symptoms targeting the end organs such as the heart, kidneys and blood vessels, and not the causes."
Sniffing out oxygen in the blood
The people who were successfully treated had naturally raised carotid body activity. At rest, they breathed more and had exaggerated breathing in response to reduced oxygen levels in the blood.
Carotid bodies normally 'sniff' the levels of oxygen in the blood and, like a thermostat, respond when levels get too low. They signal the brain to increase the breathing rate and blood pressure.
Removing a carotid body caused falls in blood pressure that were greater than BHF see through medication. This suggests the strong potential for treating high blood pressure by targeting the organ. In the future the researchers believe this could be done with a drug, which would be more practical than surgery.
New treatments are urgently needed
BHF’s Associate Medical Director, Professor Jeremy Pearson, said: "High blood pressure affects around 30 per cent of UK adults and can lead to fatal heart attacks and stroke. We urgently need to find new and better ways to treat high blood pressure and that will only be possible through research.
"By tackling the problem differently and seeking to understand the underlying causes of increased blood pressure, this BHF-funded research team has shown for the first time that removal of the carotid body can effectively reduce blood pressure in patients with resistant hypertension.
"This proof of principle clinical study is the exciting first stage in developing less invasive methods or new drugs targeting the carotid body, which can be used in future to treat patients whose blood pressure is not controlled with current medication."
Latest News from
Cancer Research UK - 1 in 5 emergency bowel cancer patients had symptoms before diagnosis29/09/2016 14:35:00
Around one in five bowel cancer patients diagnosed after an emergency presentation have displayed at least one cancer ‘alarm symptom’ in the year leading up to their diagnosis, according to a Cancer Research UK-funded study (link is external) published in the British Journal of Cancer (link is external).
BHF - Common prescription painkillers linked to increased risk of heart failure29/09/2016 12:35:00
A study has found that commonly used prescribed painkillers, used to treat pain and inflammation, are associated with an increased risk of hospitalisation for heart failure.
Cancer Research UK - Low cancer symptom awareness linked to lower chance of survival29/09/2016 10:35:00
In regions where cancer survival is poorer, people on average have lower awareness of cancer symptoms, according to new findings (link is external) published yesterday in the British Journal of Cancer(link is external)*.
Cancer Research UK - Precision medicine trial first of its kind to show benefit to patients28/09/2016 08:15:00
A clinical trial for types of advanced cancer is the first of its kind to show that precision medicine – or tailoring treatment for individual people – can slow down the time it takes for a tumour to grow back, according to research presented at the Molecular Analysis for Personalised Therapy (MAP) conference(link is external), last week.